Annals of the American Thoracic Society

Jennifer S. Guimbellot, David P. Nichols, John J. Brewington. (2022) Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis. Clinics in Chest Medicine 43:4, 617-630.
Online publication date: 1-Dec-2022.
Aduragbemi A. Faniyi, Michael J. Hughes, Aaron Scott, Kylie B. R. Belchamber, Elizabeth Sapey. (2022) Inflammation, ageing and diseases of the lung: Potential therapeutic strategies from shared biological pathways. British Journal of Pharmacology 179:9, 1790-1807.
Online publication date: 21-Jan-2022.
Martin Donnelley, Mark Gardner, Kaye Morgan, David Parsons. 2021. Non-absorptive clearance from airways. Inhaled Medicines, 197-223.
Maelle Briottet, Mickael Shum, Valerie Urbach. (2020) The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease. Frontiers in Pharmacology 11.
Online publication date: 2-Sep-2020.
Ren-Jay Shei, Kelly A. Mackintosh, Jacelyn E. Peabody Lever, Melitta A. McNarry, Stefanie Krick. (2019) Exercise Physiology Across the Lifespan in Cystic Fibrosis. Frontiers in Physiology 10.
Online publication date: 5-Nov-2019.
. (2018) Chair’s Summary: Secreted Mucins in Lung Diseases. Annals of the American Thoracic Society 15:Supplement_3, S140-S142.
Online publication date: 15-Nov-2018.
First Page | Full Text | PDF (441 KB) | Supplemental Material 


No related items
Comments Post a Comment

New User Registration

Not Yet Registered?
Benefits of Registration Include:
 •  A Unique User Profile that will allow you to manage your current subscriptions (including online access)
 •  The ability to create favorites lists down to the article level
 •  The ability to customize email alerts to receive specific notifications about the topics you care most about and special offers
Annals of the American Thoracic Society

Click to see any corrections or updates and to confirm this is the authentic version of record